HomeAI · summaries
Storia in 4 fonti
Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetes
South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement diet and exercise for adults. The company plans to launch the product soon in injectable pens. South Africa is the second market after India for this approval. This reflects Sun Pharma's commitment to improving access to generics.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Adoption of generic semaglutide depends on the delivery device
The adoption of generic semaglutide in India hinges on the clarity and simplicity of its delivery devices.
- ·
Sun Pharma gets go-ahead to sell generic semaglutide in South Africa
The approval is to treat Type II diabetes
- ·
economictimes.indiatimes.com
Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetes
South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement diet and exercise for adults. The company…
- ·
thehindu.com
Sun Pharma gets nod from South African regulator for generic semaglutide injection
Sun Pharma receives SAHPRA approval to market a generic semaglutide injection for type 2 diabetes in South Africa.
- ·
businessday.co.za
India’s Sun Pharma wins South Africa approval to launch generic Ozempic
South Africa is now the second market, after India, where the company has secured clearance for a generic semaglutide injection